Van Nostrand KM, Lucci III JA, Liao S-Y, Di Saia RJ. Primary lung choriocarcinoma masquerading as a metastatic gestational neoplasm. Gynecol Oncol 1994; 53 (3): 361–365.
Hayakawa K, Takahashi M, Sasaki K. Primary choriocarcinoma of the lung. Acta Pathol Jpn 1977; 27: 123–135.
Zapatero J, Bellon J, Baamonde C. Primary choriocarcinoma of the lung. Scand J Thorac Cardiovasc Surg 1982; 16: 279–281.
Sullivan L. Primary choriocarcinoma of the lung in a man. Arch Pathol Lab Med 1989; 113: 82–83.
Sridhar K, Saldana M, Thurer R, Beattie E. Primary choriocarcinoma of the lung: report of a case with intensive multimodality therapy and review of the literature. J Surg Oncol 1989; 41: 93–97.
Aparicio J, Oltra A, Martínez-Moragón E. Extragonadal nongestational choriocarcinoma involving the lung: a report of three cases. Respiration 1996; 63: 251–253.
Tanimura A, Natsuyama H, Kawano M. Primary choriocarcinoma of the lung. Hum Pathol 1985; 16: 1.281–1.284.
Moran CA, Suster S. Primary mediastinal choriocarcinoma: a clinicopathologic and immunohistochemical study of eight cases. Am J Surg Pathol 1997; 21 (9): 1.007–1.012.
Decker P, Bollmann R, Simianer D. Rectal cancer with choriocarcinomatous differentiation. Leber-Magen-Darm 1991; 21 (6): 285–287.
Ober W. Pathology of trophoblastic diseases. Hum Reprod 1987; 2: 143–152.
Dehner L. Gestational and nongestational trophoblastic neoplasias. Am J Surg Pathol 1980; 4: 43–58.
Germá-Lluch JR, García del Miro X, Tabemero JM, et al. BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG). Ann Oncol 1999; 10: 289–2
Bower M, Newlands ES, Holden L, et al. Treatment of men with metastatic non-seminomatous germ-cell tumors with cyclical POMB/ACE chemotherapy. Ann Oncol 1997, 8: 477–483.
Williams SD, Birch R, Einhorn LH, et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either virblastine or etoposide. N Engl J Med 1987; 316: 1.435–1.440.
De Wit R., Stoter G, Sleijfer DT, et al. Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma: a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group. Br J Cancer 1995; 71:1.311–1.314.